Related Experiment Video
Updated: Aug 17, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p53-A pro-apoptotic signal transducer involved in AIDS
Maria Castedo1, Jean-Luc Perfettini, Mauro Piacentini
1CNRS-UMR8125, Institut Gustave Roussy, 39 rue Camille-Desmoulins, F-94805 Villejuif, France.
Abstract:
P53 is a well-characterized tumor suppressor protein, which can induce apoptosis, either by inducing transcription of pro-apoptotic genes or by direct effects on mitochondrial membranes. Roughly 50% of human cancers are affected by the genetic or epigenetic inactivation of p53. Recently, p53 has been incriminated to play a cardinal role in the destruction of the immune system by human immunodeficiency virus (HIV-1) infection. This suspicion is based on several lines of evidence: (i) p53 exhibits activating phosphorylations in a subset of peripheral blood mononuclear cells and lymph node cells from HIV-1 carriers; (ii) some p53 target genes (e.g., PUMA, a pro-apoptotic member of the Bcl-2 family) are overexpressed in HIV-1 carriers; (iii) in vitro, p53 and/or PUMA are rate-limiting for the induction of cell death by HIV-1 infection or, in particular, by the HIV-1 Envelope (Env), in a variety of model systems, including the apoptosis of syncytia elicited by Env or cell death induced by the Env constituent gp120. Thus, p53 may constitute a novel therapeutic target for the treatment of AIDS.
Insights
The p53 protein, a known tumor suppressor, plays a key role in immune system destruction during human immunodeficiency virus (HIV-1) infection. Targeting p53 offers a potential new therapeutic strategy for acquired immunodeficiency syndrome (AIDS).
Area of Science:
- Oncology
- Immunology
- Virology
Background:
- p53 is a critical tumor suppressor protein inducing apoptosis.
- Genetic or epigenetic inactivation of p53 affects approximately 50% of human cancers.
- Recent evidence implicates p53 in the immune system destruction caused by HIV-1 infection.
Purpose of the Study:
- To investigate the role of p53 in HIV-1-mediated immune system damage.
- To explore p53 as a potential therapeutic target for AIDS treatment.
Main Methods:
- Analysis of p53 activating phosphorylations in cells from HIV-1 carriers.
- Measurement of p53 target gene expression (e.g., PUMA) in HIV-1 carriers.
- In vitro studies assessing the role of p53 and PUMA in HIV-1-induced cell death, including Env-mediated apoptosis.
Main Results:
- p53 showed activating phosphorylations in immune cells of HIV-1 carriers.
- Overexpression of p53 target genes, such as PUMA, was observed in HIV-1 carriers.
- In vitro experiments confirmed p53 and PUMA as rate-limiting factors in HIV-1-induced cell death, particularly via the HIV-1 Envelope (Env) and gp120.
Conclusions:
- p53 activation and its target genes are involved in HIV-1-induced immune cell death.
- p53 may be a novel therapeutic target for acquired immunodeficiency syndrome (AIDS).
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
DNA Damage Can Stall the Cell Cycle
PI3K/mTOR/AKT Signaling Pathway

